The news. The narrative. The timeline.
Day 19 — 32,575 acres, 65 percent contained, exceptional drought, no replacement smoke-forecast capacity, and the Highway 82 Fire 22,471 acres at 75 percent.
Sweden's 95,000-person semaglutide cohort says depression risk drops 44 percent; a propensity-matched comparator says it rises — and both designs sit next to a two-million-script U.S. base.
Twenty-four days into the public methodology fight, NICE's final draft says donanemab does not pass cost-effectiveness — and the June 10 meeting is the only document that changes that.
Day 10 of Section 6E: Flaming Gorge releases run, August power-pool cliff still looms, and Utah mediation joins Page Utility's 40-to-20 disclosure as the operative reading.
Utah's outbreak holds at 638 cases — 441 in 2026 — and a May 6 Lancet letter names the U.S. 'highly likely' to lose elimination status when PAHO meets in November.
Day 3 of APHIS's lactating-dairy testing exemption — Idaho still holds 17-plus confirmed dairies in quarantine while the artificial-insemination vector hypothesis stays unresolved.
McGill's cytogel hits 13x fracture toughness, 4x adhesion, sub-five-second formation — and outperforms the clinical product in rodent liver hemorrhage.
Penn-led WIHS analysis: monocyte epigenetic age — but not multi-tissue clocks — predicts non-somatic depression in 440 women, sharpening the assay against the somatic-symptom confound.
LHCb-PAPER-2025-041 anchors the four-sigma B0 K* anomaly at 8.4 inverse femtobarns; Run 3 has cleared roughly three times the 2018 set; discovery sits in the 2030s.
Copernicus Marine: April 2026 SST 21.08°C, second-warmest April after 2024; equatorial Pacific hit 26.99°C — warmest April there ever recorded.
Day 9 of a peer-reviewed Science paper showing the CDC's revised autism page measurably lowers vaccination intent and amplifies science-denial reasoning in 3,000 adults.
AHA's April 23 tribute and NHLBI's May 5 director message frame Braunwald as 'father of modern cardiology' — the same week federal cardiology research budgets are being cut.
Becle's Q1 net profit fell 67 percent and U.S. sales 36.6 percent — Cinco's Day 4 receipt is the world's largest tequila maker hitting the holiday on a distributor switch, not a tailwind.